A Predictive Model of the HIV Infection Course

E. Veselova, G. Kaminskiy, K. A. Kocharyan, A. B. Peregudova, O. V. Lovacheva, A. G. Samoylova
{"title":"A Predictive Model of the HIV Infection Course","authors":"E. Veselova, G. Kaminskiy, K. A. Kocharyan, A. B. Peregudova, O. V. Lovacheva, A. G. Samoylova","doi":"10.58838/2075-1230-2024-102-1-6-11","DOIUrl":null,"url":null,"abstract":"The course of HIV infection depends on the degree of HIV suppression during ART.The objective: to evaluate feasibility of using three factors: viral load (VL), HIV reservoir and CD8 T cells before ART initiation to estimate future levels of “residual” viremia and develop a predictive model.Subjects and Methods. 74 naive patients with HIV infection were enrolled in the study. The HIV reservoir, VL and CD4, CD8 counts were tested before ART initiation and then every 6 months. The patients were followed up for 12 months. Discriminant analysis was used.Results. After 12 months of ART, 69/74 (93.2%) patients had undetectable VL including 14 patients with residual viremia (RV) and 55 in whom no virus was detected. The probability of persisting RV after 12 months of ART was assessed first by one factor – VL prior to ART, after that by three factors – VL, HIV reservoir (HIV DNA), CD8 count prior to ART. A predictive model formula was generated using those factors: D = -5.288-0.001 CD8+1.342VL+0.08 HIV DNA. With discriminant function D>0.065, the patient has a high probability of RV after 12 months of ART; with D ≤0.065, the probability of RV is low. This prognosis should be taken into account when choosing an ART regimen ensuring its maximum optimization.","PeriodicalId":37828,"journal":{"name":"Tuberculosis and Lung Diseases","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tuberculosis and Lung Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.58838/2075-1230-2024-102-1-6-11","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

The course of HIV infection depends on the degree of HIV suppression during ART.The objective: to evaluate feasibility of using three factors: viral load (VL), HIV reservoir and CD8 T cells before ART initiation to estimate future levels of “residual” viremia and develop a predictive model.Subjects and Methods. 74 naive patients with HIV infection were enrolled in the study. The HIV reservoir, VL and CD4, CD8 counts were tested before ART initiation and then every 6 months. The patients were followed up for 12 months. Discriminant analysis was used.Results. After 12 months of ART, 69/74 (93.2%) patients had undetectable VL including 14 patients with residual viremia (RV) and 55 in whom no virus was detected. The probability of persisting RV after 12 months of ART was assessed first by one factor – VL prior to ART, after that by three factors – VL, HIV reservoir (HIV DNA), CD8 count prior to ART. A predictive model formula was generated using those factors: D = -5.288-0.001 CD8+1.342VL+0.08 HIV DNA. With discriminant function D>0.065, the patient has a high probability of RV after 12 months of ART; with D ≤0.065, the probability of RV is low. This prognosis should be taken into account when choosing an ART regimen ensuring its maximum optimization.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
艾滋病毒感染过程的预测模型
艾滋病病毒感染的过程取决于抗逆转录病毒疗法(ART)期间艾滋病病毒的抑制程度。目的:评估使用抗逆转录病毒疗法启动前的病毒载量(VL)、艾滋病病毒储库和 CD8 T 细胞这三个因素来估计未来 "残余 "病毒血症水平并开发预测模型的可行性。研究共招募了 74 名天真的 HIV 感染者。在开始接受抗逆转录病毒疗法前检测 HIV 储库、VL 和 CD4、CD8 细胞计数,然后每 6 个月检测一次。对患者进行了为期 12 个月的随访。研究采用了判别分析。抗逆转录病毒疗法 12 个月后,69/74(93.2%)名患者检测不到 VL,其中包括 14 名残留病毒血症(RV)患者和 55 名未检测到病毒的患者。评估抗逆转录病毒疗法 12 个月后 RV 持续存在的概率时,首先考虑一个因素--抗逆转录病毒疗法前的 VL,然后考虑三个因素--抗逆转录病毒疗法前的 VL、HIV 储库(HIV DNA)和 CD8 细胞数。利用这些因素生成了一个预测模型公式:D = -5.288-0.001 CD8+1.342VL+0.08 HIV DNA。当判别函数 D>0.065 时,患者在接受抗逆转录病毒疗法 12 个月后出现 RV 的概率较高;当 D≤0.065 时,出现 RV 的概率较低。在选择抗逆转录病毒疗法时应考虑到这一预后,以确保最大限度地优化疗法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Tuberculosis and Lung Diseases
Tuberculosis and Lung Diseases Medicine-Pulmonary and Respiratory Medicine
CiteScore
1.20
自引率
0.00%
发文量
88
审稿时长
8 weeks
期刊介绍: The Journal is aimed for professional development of researchers, doctors, teachers of medical universities and training institutions. The Journal focuses on the presentation of results of research, case studies, issues of differential diagnostics and treatment in the phthisiologist’s practice, national programs on tuberculosis control in the Russian Federation, WHO strategies, discussion of prevention issues to stop transmission of TB/HIVco-infection, and extrapulmonary tuberculosis.
期刊最新文献
Treatment Results in Patients with Drug Resistant Tuberculosis (MDR, pre-XDR, XDR) and HIV Infection in Stavropol Region Impact of the COVID-19 Restrictive Measures on Tuberculosis Detection among Children and Adolescents Sarcoidosis Phenotyping: Analysis of Current Approaches (Review) Postponed Results of Lung Resections for Disseminated Fibrous Cavernous Tuberculosis Lung Imaging for Suspected Tuberculosis in the Pregnant (Review)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1